Unique ID issued by UMIN | UMIN000006876 |
---|---|
Receipt number | R000007547 |
Scientific Title | A prospective study to evaluate the efficacy of proactive management in infantile atopic dermatitis for prevention of sensitization to house dust mite and atopic march |
Date of disclosure of the study information | 2012/01/01 |
Last modified on | 2013/12/20 22:56:13 |
A prospective study to evaluate the efficacy of proactive management in infantile atopic dermatitis for prevention of sensitization to house dust mite and atopic march
A prospective study to evaluate the efficacy of proactive management for prevention of atopic march
A prospective study to evaluate the efficacy of proactive management in infantile atopic dermatitis for prevention of sensitization to house dust mite and atopic march
A prospective study to evaluate the efficacy of proactive management for prevention of atopic march
Japan |
atopic dermatitis
Clinical immunology | Pediatrics | Dermatology |
Others
NO
To evaluate the efficacy of proactive management in infantile atopic dermatitis for prevention of sensitization to house dust mite and Japanese cedar pollen
Efficacy
Confirmatory
Pragmatic
Not applicable
House dust mite specific IgE and house dust mite specific lymphocyte stimulation test [Time Frame: 24 months]
Japanese cedar pollen specific IgE and specific lymphocyte stimulation test [Time Frame: 24 months]
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Behavior,custom |
A proactive approach by using topical corticosteroids (i.e. twice-a-week) to all previously identified affected areas with confirmation of no exacerbation.
At exacerbation, patients apply topical corticosteroids everyday and subsequently return proactive application to any new skin areas where AD lesions have appeared.
A conventional treatment with emollient and daily skin care, using topical corticosteroids when flare.
0 | years-old | <= |
2 | years-old | > |
Male and Female
Eligible patients are boys and girls aged 3 to 24 months with a diagnosis of atopic dermatitis or infantile eczema.
The exclusion criteria is as followed; (1) The patients receiving any additional systemic therapies included corticosteroids, nonsteroidal immunosuppressive agents or biological immunotherapy, (2) the patients who has a past history of cardiovascular disease, liver dysfunction, kidney disease and other current serious medical problems.
50
1st name | |
Middle name | |
Last name | Tatsuki Fukuie |
Hamamatsu University School of Medicine
Department of Pediatrics
Handayama 1-20-1, Higashiku, Hamamatsushi,Shizuokaken, JAPAN
053-435-2312
fukuie-t@hama-med.ac.jp
1st name | |
Middle name | |
Last name | Tatsuki Fukuie |
Hamamatsu University School of Medicine
Department of Pediatrics
Handayama 1-20-1, Higashiku, Hamamatsushi,Shizuokaken, JAPAN
053-435-2312
http://square.umin.ac.jp/hamaped/
fukuie-t@hama-med.ac.jp
Department of Pediatrics, Hamamatsu University School of Medicine
Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Young Scientists B (No.23791165)
Japan
NO
浜松医科大学附属病院(静岡県)
2012 | Year | 01 | Month | 01 | Day |
Unpublished
Open public recruiting
2011 | Year | 10 | Month | 01 | Day |
2012 | Year | 01 | Month | 01 | Day |
2011 | Year | 12 | Month | 12 | Day |
2013 | Year | 12 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007547